Subjects ->
STATISTICS (Total: 130 journals)
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
[Sort by number of followers ] [Restore default list ]
Showing 1 - 151 of 151 Journals sorted alphabetically
Advances in Complex Systems (Followers: 10) Advances in Data Analysis and Classification (Followers: 61) Annals of Applied Statistics (Followers: 39) Applied Categorical Structures (Followers: 4) Argumentation et analyse du discours (Followers: 10) Asian Journal of Mathematics & Statistics (Followers: 8) AStA Advances in Statistical Analysis (Followers: 4) Australian & New Zealand Journal of Statistics (Followers: 13) Bernoulli (Followers: 9) Biometrical Journal (Followers: 10) Biometrics (Followers: 51) British Journal of Mathematical and Statistical Psychology (Followers: 18) Building Simulation (Followers: 1) Bulletin of Statistics (Followers: 4) CHANCE (Followers: 5) Communications in Statistics - Simulation and Computation (Followers: 9) Communications in Statistics - Theory and Methods (Followers: 11) Computational Statistics (Followers: 14) Computational Statistics & Data Analysis (Followers: 37) Current Research in Biostatistics (Followers: 8) Decisions in Economics and Finance (Followers: 11) Demographic Research (Followers: 16) Electronic Journal of Statistics (Followers: 8) Engineering With Computers (Followers: 5) Environmental and Ecological Statistics (Followers: 7) ESAIM: Probability and Statistics (Followers: 5) Extremes (Followers: 2) Fuzzy Optimization and Decision Making (Followers: 8) Geneva Papers on Risk and Insurance - Issues and Practice (Followers: 13) Handbook of Numerical Analysis (Followers: 5) Handbook of Statistics (Followers: 7) IEA World Energy Statistics and Balances - (Followers: 2) International Journal of Computational Economics and Econometrics (Followers: 6) International Journal of Quality, Statistics, and Reliability (Followers: 17) International Journal of Stochastic Analysis (Followers: 3) International Statistical Review (Followers: 12) International Trade by Commodity Statistics - Statistiques du commerce international par produit Journal of Algebraic Combinatorics (Followers: 4) Journal of Applied Statistics (Followers: 20) Journal of Biopharmaceutical Statistics (Followers: 20) Journal of Business & Economic Statistics (Followers: 39, SJR: 3.664, CiteScore : Journal of Combinatorial Optimization (Followers: 7) Journal of Computational & Graphical Statistics (Followers: 20) Journal of Econometrics (Followers: 82) Journal of Educational and Behavioral Statistics (Followers: 6) Journal of Forecasting (Followers: 17) Journal of Global Optimization (Followers: 7) Journal of Interactive Marketing (Followers: 10) Journal of Mathematics and Statistics (Followers: 8) Journal of Nonparametric Statistics (Followers: 6) Journal of Probability and Statistics (Followers: 10) Journal of Risk and Uncertainty (Followers: 32) Journal of Statistical and Econometric Methods (Followers: 5) Journal of Statistical Physics (Followers: 13) Journal of Statistical Planning and Inference (Followers: 8) Journal of Statistical Software (Followers: 20, SJR: 13.802, CiteScore : Journal of the American Statistical Association (Followers: 72, SJR: 3.746, CiteScore : Journal of the Korean Statistical Society (Followers: 1) Journal of the Royal Statistical Society Series C (Applied Statistics) (Followers: 31) Journal of the Royal Statistical Society, Series A (Statistics in Society) (Followers: 26) Journal of the Royal Statistical Society, Series B (Statistical Methodology) (Followers: 43) Journal of Theoretical Probability (Followers: 3) Journal of Time Series Analysis (Followers: 16) Journal of Urbanism: International Research on Placemaking and Urban Sustainability (Followers: 30) Law, Probability and Risk (Followers: 8) Lifetime Data Analysis (Followers: 7) Mathematical Methods of Statistics (Followers: 4) Measurement Interdisciplinary Research and Perspectives (Followers: 1) Metrika (Followers: 4) Modelling of Mechanical Systems (Followers: 1) Monte Carlo Methods and Applications (Followers: 6) Monthly Statistics of International Trade - Statistiques mensuelles du commerce international (Followers: 2) Multivariate Behavioral Research (Followers: 5) Optimization Letters (Followers: 2) Optimization Methods and Software (Followers: 8) Oxford Bulletin of Economics and Statistics (Followers: 34) Pharmaceutical Statistics (Followers: 17) Probability Surveys (Followers: 4) Queueing Systems (Followers: 7) Research Synthesis Methods (Followers: 7) Review of Economics and Statistics (Followers: 124) Review of Socionetwork Strategies Risk Management (Followers: 15) Sankhya A (Followers: 2) Scandinavian Journal of Statistics (Followers: 9) Sequential Analysis: Design Methods and Applications Significance (Followers: 7) Sociological Methods & Research (Followers: 37) SourceOCDE Comptes nationaux et Statistiques retrospectives SourceOCDE Statistiques : Sources et methodes SourceOECD Bank Profitability Statistics - SourceOCDE Rentabilite des banques (Followers: 1) SourceOECD Insurance Statistics - SourceOCDE Statistiques d'assurance (Followers: 2) SourceOECD Main Economic Indicators - SourceOCDE Principaux indicateurs economiques (Followers: 1) SourceOECD Measuring Globalisation Statistics - SourceOCDE Mesurer la mondialisation - Base de donnees statistiques SourceOECD Monthly Statistics of International Trade (Followers: 1) SourceOECD National Accounts & Historical Statistics SourceOECD OECD Economic Outlook Database - SourceOCDE Statistiques des Perspectives economiques de l'OCDE (Followers: 2) SourceOECD Science and Technology Statistics - SourceOCDE Base de donnees des sciences et de la technologie SourceOECD Statistics Sources & Methods (Followers: 1) SourceOECD Taxing Wages Statistics - SourceOCDE Statistiques des impots sur les salaires Stata Journal (Followers: 9) Statistica Neerlandica (Followers: 1) Statistical Applications in Genetics and Molecular Biology (Followers: 5) Statistical Communications in Infectious Diseases Statistical Inference for Stochastic Processes (Followers: 3) Statistical Methodology (Followers: 7) Statistical Methods and Applications (Followers: 6) Statistical Methods in Medical Research (Followers: 27) Statistical Modelling (Followers: 19) Statistical Papers (Followers: 4) Statistical Science (Followers: 13) Statistics & Probability Letters (Followers: 13) Statistics & Risk Modeling (Followers: 2) Statistics and Computing (Followers: 13) Statistics and Economics (Followers: 1) Statistics in Medicine (Followers: 191) Statistics, Politics and Policy (Followers: 6) Statistics: A Journal of Theoretical and Applied Statistics (Followers: 14) Stochastic Models (Followers: 3) Stochastics An International Journal of Probability and Stochastic Processes: formerly Stochastics and Stochastics Reports (Followers: 2) Structural and Multidisciplinary Optimization (Followers: 12) Teaching Statistics (Followers: 7) Technology Innovations in Statistics Education (TISE) (Followers: 2) TEST (Followers: 3) The American Statistician (Followers: 24) The Annals of Applied Probability (Followers: 8) The Annals of Probability (Followers: 10) The Annals of Statistics (Followers: 34) The Canadian Journal of Statistics / La Revue Canadienne de Statistique (Followers: 11) Wiley Interdisciplinary Reviews - Computational Statistics (Followers: 1)
[Sort by number of followers ] [Restore default list ]
Issue Information Abstract: Pharmaceutical Statistics, Volume 20, Issue 1, Page 1-3, January/February 2021.Citation: Pharmaceutical StatisticsPubDate: 2021-01-14T01:23:02-08:00DOI: 10.1002/pst.2033Issue No: Vol. 20, No. 1 (2021) Assessing efficacy in important subgroups in confirmatory trials: An Authors:
Nicky Best; Robert G. Price,
Isabelle J. Pouliquen,
Oliver N. Keene Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2021-01-21T03:42:07-08:00DOI: 10.1002/pst.2093A Bayesian adaptive design for biosimilar trials with Authors:
Sheferaw Y. Belay; Rongji Mu,
Jin Xu Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2021-01-20T10:59:40-08:00DOI: 10.1002/pst.2096A novel equivalence probability weighted power prior for using historical Authors:
Maxine Bennett; Simon White,
Nicky Best,
Adrian Mander Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2021-01-20T08:38:06-08:00DOI: 10.1002/pst.2088Designing and analyzing clinical trials for personalized medicine via Authors:
Chuanwu Zhang; Matthew S. Mayo,
Jo A. Wick,
Byron J. Gajewski Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2021-01-19T03:01:09-08:00DOI: 10.1002/pst.2095A weighted log‐rank test and associated effect estimator for cancer Authors:
Chang Yu; Xiang Huang,
Hui Nian,
Philip He Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2021-01-11T05:07:52-08:00DOI: 10.1002/pst.2092Non‐proportional hazards in immuno‐oncology: Is an old Authors:
Dominic Magirr
Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-12-22T03:10:58-08:00DOI: 10.1002/pst.2091Sample size calculations for single‐arm survival studies using Authors:
Kengo Nagashima; Hisashi Noma,
Yasunori Sato,
Masahiko Gosho Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-12-21T09:50:02-08:00DOI: 10.1002/pst.2090A confidence function‐based posterior probability design for phase Authors:
Minghua Shan
Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-12-18T02:38:45-08:00DOI: 10.1002/pst.2089A class of goodness‐of‐fit test for the additive hazards model with Authors:
Yongxiu Cao; Jichang Yu Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-12-10T09:12:30-08:00DOI: 10.1002/pst.2087Novel concentration‐QTc models for early clinical studies with parallel Authors:
Yasushi Orihashi; Yuji Kumagai,
Kazuhito Shiosakai Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-12-08T05:09:58-08:00DOI: 10.1002/pst.2083Early stopping in seamless phase I/II clinical trials Authors:
Noor M. Khan; M. Iftakhar Alam Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-12-07T02:00:36-08:00DOI: 10.1002/pst.2084Bayesian optimization design for dose‐finding based on toxicity and Authors:
Ami Takahashi; Taiji Suzuki Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-11-30T11:19:29-08:00DOI: 10.1002/pst.2085Adjusting win statistics for dependent censoring Authors:
Gaohong Dong; Bo Huang,
Duolao Wang,
Johan Verbeeck,
Jiuzhou Wang,
David C. Hoaglin Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-11-28T12:56:14-08:00DOI: 10.1002/pst.2086Dynamic ordering design for dose finding in drug‐combination trials Authors:
Teng Zhang; Zhao Yang,
Guosheng Yin Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-11-24T10:57:01-08:00DOI: 10.1002/pst.2081Joint analysis of longitudinal measurements and survival times with a cure Authors:
Lu Yang; Hui Song,
Yingwei Peng,
Dongsheng Tu Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-11-22T10:44:49-08:00DOI: 10.1002/pst.2082Estimand framework: Are we asking the right questions' A case study in Authors:
Michelle Casey; Evgeny Degtyarev,
María José Lechuga,
Paola Aimone,
Alain Ravaud,
Robert J. Motzer,
Feng Liu,
Viktoriya Stalbovskaya,
Rui Tang,
Emily Butler,
Oliver Sailer,
Susan Halabi,
Daniel George Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-11-05T10:48:59-08:00DOI: 10.1002/pst.2079Assessment of the information theory approach to evaluating Authors:
Natalie Dimier; Susan Todd Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-11-03T08:15:36-08:00DOI: 10.1002/pst.2080Assessing and communicating heterogeneity of treatment effects for patient Authors:
Mark Rothmann; William Crown,
Thomas A. Louis,
Thomas Permutt,
Stephen Ruberg,
Jodi Segal,
John Scott Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-10-28T09:05:37-07:00DOI: 10.1002/pst.2077Resampling‐based stepwise multiple testing procedures with Authors:
Jiwei He; Feng Li,
Yan Gao,
Mark Rothmann Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-10-25T11:40:27-07:00DOI: 10.1002/pst.2076Defining estimands using a mix of strategies to handle intercurrent events Authors:
Yongming Qu; Linda Shurzinske,
Shanthi Sethuraman Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-10-23T09:04:41-07:00DOI: 10.1002/pst.2078Assessing goodness‐of‐fit for evaluation of Authors:
Martin J. Wolfsegger; Alexander Bauer,
Detlew Labes,
Helmut Schütz,
Richardus Vonk,
Benjamin Lang,
Stephan Lehr,
Thomas F. Jaki,
Werner Engl,
Michael D. Hale Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-10-15T11:03:21-07:00DOI: 10.1002/pst.2074Utilizing Bayesian predictive power in clinical trial design Authors:
Ofir Harari; Grace Hsu,
Louis Dron,
Jay J. H. Park,
Kristian Thorlund,
Edward J. Mills Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-10-08T09:26:21-07:00DOI: 10.1002/pst.2073TSNP: A two‐stage nonparametric phase I/II clinical trial design for Authors:
Yan Han; Hao Liu,
Sha Cao,
Chi Zhang,
Yong Zang Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-10-06T08:37:25-07:00DOI: 10.1002/pst.2075The current state of Bayesian methods in nonclinical pharmaceutical Authors:
Paul Faya; Perceval Sondag,
Steven Novick,
Dwaine Banton,
John W. Seaman, Jr,
James D. Stamey,
Bruno Boulanger Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-10-06T07:46:21-07:00DOI: 10.1002/pst.2072Recurrent time‐to‐event models with ordinal outcomes Authors:
Val Gebski; Karen Byth,
Rebecca Asher,
Ian Marschner Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-10-02T12:06:25-07:00DOI: 10.1002/pst.2057Assessing the quality of studies in meta‐research: Review/guidelines on Authors:
Claudio Luchini; Nicola Veronese,
Alessia Nottegar,
Jae Il Shin,
Giovanni Gentile,
Umberto Granziol,
Pinar Soysal,
Ovidiu Alexinschi,
Lee Smith,
Marco Solmi Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-09-15T10:40:06-07:00DOI: 10.1002/pst.2068Sample size calculation for logrank test and prediction of number of Authors:
Kaifeng Lu
Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-09-09T07:04:11-07:00DOI: 10.1002/pst.2069Estimands in practice: Bridging the gap between study objectives and Authors:
Alan Phillips; Tim Clark Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-09-07T12:24:45-07:00DOI: 10.1002/pst.2056The promise and pitfalls of composite endpoints in sepsis and Authors:
P. M. Brown; Tormod Rogne,
Erik Solligård Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-09-07T03:55:20-07:00DOI: 10.1002/pst.2070Comments on “Incorporating historical two‐arm data in clinical trials Authors:
Annette Kopp‐Schneider
Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-09-02T09:24:42-07:00DOI: 10.1002/pst.2061Use of a two‐sided tolerance interval in the design and evaluation of Authors:
Chieh Chiang; Chi‐Tian Chen,
Chin‐Fu Hsiao Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-09-01T03:49:58-07:00DOI: 10.1002/pst.2065Cancer immunotherapy trial design with long‐term survivors Authors:
Xue Ding; Jianrong Wu Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-09-01T03:14:16-07:00DOI: 10.1002/pst.2060A pragmatic adaptive enrichment design for selecting the right target Authors:
Anh Nguyen Duc; Dominik Heinzmann,
Claude Berge,
Marcel Wolbers Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-09-01T01:22:18-07:00DOI: 10.1002/pst.2066A stochastically curtailed two‐arm randomised phase II trial design Authors:
Martin Law; Michael J. Grayling,
Adrian P. Mander Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-08-29T04:23:36-07:00DOI: 10.1002/pst.2067Delayed treatment effects, treatment switching and heterogeneous patient Authors:
Robin Ristl; Nicolás M Ballarini,
Heiko Götte,
Armin Schüler,
Martin Posch,
Franz König Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-08-23T11:26:41-07:00DOI: 10.1002/pst.2062Evaluation of alternative confidence intervals to address Authors:
Jiatong Sui; Jenny Jiao,
Yijun Sun,
Jeen Liu,
Rowena Bastero,
Gary Koch Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-08-20T08:59:44-07:00DOI: 10.1002/pst.2063A method for sample size calculation via E‐value in the planning of Authors:
Yixin Fang; Weili He,
Xiaofei Hu,
Hongwei Wang Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-08-20T05:59:37-07:00DOI: 10.1002/pst.2064Augmented inverse probability weighted fractional imputation in quantile Authors:
Hao Cheng
Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-08-18T03:27:20-07:00DOI: 10.1002/pst.2052An application of the mixed‐effects model and pattern mixture model to Authors:
Masahiko Gosho; Kazushi Maruo Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-08-16T09:49:01-07:00DOI: 10.1002/pst.2058Controlling type I error rates in multi‐arm clinical trials: A case for Authors:
James M. S. Wason; David S. Robertson Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-08-12T06:43:35-07:00DOI: 10.1002/pst.2059To use or not to use propensity score matching' Authors:
Jixian Wang
Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-08-10T06:03:02-07:00DOI: 10.1002/pst.2051Implementation of tripartite estimands using adherence causal estimators Authors:
Yongming Qu; Junxiang Luo,
Stephen J. Ruberg Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-08-10T01:25:44-07:00DOI: 10.1002/pst.2054Prior distributions for variance parameters in a sparse‐event Authors:
Konstantinos Pateras; Stavros Nikolakopoulos,
Kit C. B. Roes Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-08-06T06:35:16-07:00DOI: 10.1002/pst.2053Designing historical control studies with survival endpoints using exact Authors:
Gang Han
Abstract: Pharmaceutical Statistics, EarlyView.Citation: Pharmaceutical StatisticsPubDate: 2020-08-03T12:40:13-07:00DOI: 10.1002/pst.2050
Hybrid journal (It can contain Open Access articles)
